Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-23-005476

Options or other derivatives

  • Director acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Koppel Adam Director 2023-06-21 Grant or award · Stock Option (right to buy) +16,000 16,000 D
Loading xslF345X04/primarydocument.xml…